Rac’n’rolling the immune system
In this issue of Blood, Donkó et al report the clinical and biological features of a unique cohort of 54 patients from 37 families with Ras-related C3 botu
In this issue of Blood, Donkó et al report the clinical and biological features of a unique cohort of 54 patients from 37 families with Ras-related C3 botu
Exposure to propofol was associated with an increased risk of impairment in reaction time/processing speed at 1 year after treatment in children with high-risk B-cell…
A 23-year-old man presented with leukopenia and thrombocytopenia persisting for four years. He complained of occasional epistaxis and easy bruising every f
Sharon Dent, Ph.D., professor of Epigenetics and Molecular Carcinogenesis, and dean of the Graduate School of Biomedical Sciences at The University of Texas MD Anderson…
Based on results from the phase 3 innovaTV 301 trial, the FDA has approved tisotumab vedotin for patients with recurrent or metastatic cervical cancer who…
The United States Preventive Services Task Force final breast cancer screening recommendation statement advises that women aged 40 begin biennial screening.
Ariel Lopez-Chavez, MD, discusses the potential of tarlatamab and its use in the frontline setting for the treatment of patients with small cell lung cancer.
Topline results from the REMOVE certification study showed that Lindis Blood Care’s medical device Catuvab was safe and effective, meeting all primary and secondary endpoints. …
Learn how advanced basal cell carcinoma can be treated with a new combination radiation and drug therapy.
A preclinical study suggests that the addition of a component of the ketogenic diet—a preketone dietary supplement—to immunotherapy may potentially be effective in treating prostate…
53 receive Dean’s Impact Awards for teaching, guiding, inspiring, advocating